Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Sesma-Sanz

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Epigenetics|March 11, 2021
Synergistic effects of type I PRMT and PARP inhibitors against non-small cell lung cancer cellsClaudia Dominici, Nicolas Sgarioto, Zhenbao Yu, et al.
Breast Cancer Research : BCR|January 27, 2019
p53 controls the plasticity of mammary luminal progenitor cells downstream of Met signalingAurélie Chiche, Amandine Di-Cicco, Laura Sesma-Sanz, et al.
Trends in Biochemical Sciences|January 15, 2019
The Tumor Suppressor PALB2: Inside OutMandy Ducy, Laura Sesma-Sanz, Laure Guitton-Sert, et al.
Science Advances|November 12, 2025
Glial-to-mesenchymal transition of tumor Schwann cells drives the genetic burden in MPNSTs from neurofibromatosis type 1 mouse modelKatarzyna J Radomska, Audrey Onfroy, Laure Lecerf, et al.
Nucleic Acids Research|February 9, 2022
RAD51 protects against nonconservative DNA double-strand break repair through a nonenzymatic functionAyeong So, Elodie Dardillac, Ali Muhammad, et al.
Plos One|February 20, 2024
Sperm Toolbox-A selection of small molecules to study human spermatozoaFranz S Gruber, Anthony Richardson, Zoe C Johnston, et al.
Genes & Development|February 27, 2019
BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanomaKatharine Herbert, Romuald Binet, Jean-Philippe Lambert, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Epigenetics|March 11, 2021
Synergistic effects of type I PRMT and PARP inhibitors against non-small cell lung cancer cellsClaudia Dominici, Nicolas Sgarioto, Zhenbao Yu, et al.
Breast Cancer Research : BCR|January 27, 2019
p53 controls the plasticity of mammary luminal progenitor cells downstream of Met signalingAurélie Chiche, Amandine Di-Cicco, Laura Sesma-Sanz, et al.
Trends in Biochemical Sciences|January 15, 2019
The Tumor Suppressor PALB2: Inside OutMandy Ducy, Laura Sesma-Sanz, Laure Guitton-Sert, et al.
Science Advances|November 12, 2025
Glial-to-mesenchymal transition of tumor Schwann cells drives the genetic burden in MPNSTs from neurofibromatosis type 1 mouse modelKatarzyna J Radomska, Audrey Onfroy, Laure Lecerf, et al.
Nucleic Acids Research|February 9, 2022
RAD51 protects against nonconservative DNA double-strand break repair through a nonenzymatic functionAyeong So, Elodie Dardillac, Ali Muhammad, et al.
Plos One|February 20, 2024
Sperm Toolbox-A selection of small molecules to study human spermatozoaFranz S Gruber, Anthony Richardson, Zoe C Johnston, et al.
Genes & Development|February 27, 2019
BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanomaKatharine Herbert, Romuald Binet, Jean-Philippe Lambert, et al.
Pageof 1